Comfortable, fast, reliable early diagnosis
Colo-Check offers a patient-friendly and molecular-based early diagnosis solution in colorectal cancer screening, allowing patients to provide samples without the invasive burden of colonoscopy.
Patients with a positive test result are referred for colonoscopy; in patients with a negative result, the aim is to reduce unnecessary invasive procedures.
Dual matrix panel approach
Stool + SerumStool analysis
Screening of epigenetic cancer traces with a 6-gene panel.
Serum analysis
Supportive confirmation from a blood sample with a 3-gene panel.
Sensitivity
Performance reported in dual-matrix clinical study data.
Hybrid molecular solution
Dual matrix technology that does not depend on a single sample type
The distinctive aspect of Colo-Check is its ability to simultaneously analyze both stool and serum samples taken from the same patient. This approach helps evaluate epigenetic cancer traces through cross-validation.
Stool analysis only
Provides 80.0% sensitivity and 93.7% specificity data with a 6-gene panel.
Serum analysis only
Provides 75.7% sensitivity and 94.3% specificity data with a 3-gene panel.
Stool + serum panel
Reaches 90.6% sensitivity and 95.0% specificity with the dual matrix approach.
%90
High success rate in the early stage
The survival rate in cancer treatment increases significantly when the disease is diagnosed at an early stage. Colo-Check aims to increase the chance of intervention before cancer shows clinical symptoms or reaches advanced stages.
Clinical studies have stated that Colo-Check maintains approximately 90% sensitivity and 90% specificity performance in Stage I and II tumors.
Comparison
Colonoscopy, Colo-Check and FIT test
Colo-Check stands apart from traditional screening options with its non-invasive structure aimed at increasing patient compliance and its dual-matrix molecular panel performance.
| Criteria | Colonoscopy | Colo-Check | FIT |
|---|---|---|---|
| Sensitivity | >%95 | %90,6 | ~%74 |
| Specificity | High | %95,0 | ~%94 |
| Invasiveness | Invasive, requires sedation | Non-invasive | Non-invasive |
| Patient compliance | Low | Very high | High |
*Real data obtained from the clinical study is presented.
ÜTS registration
Medical device registered in the Republic of Turkey Ministry of Health Product Tracking System
ÜTS Registration: Colo-Check is a medical device registered in the Republic of Turkey Ministry of Health Product Tracking System. Start date: 03/07/2025.
